title: Brivudin induced delirium: a case report.
abstract: Brivudin is an oral antiviral agent used to treat herpes zoster infections. Common side effects of brivudin include nausea and headache. This report describes delirium in a patient who used brivudin for herpes zoster treatment, which consequently remitted after drug cessation on the  fourth day of medication use. To our knowledge, no such side effect has been reported to date. However, it is important that clinicians who prescribe brivudin are aware that treatment cessation is likely to result in total clinical recovery.
authors.affiliation: Department of Infectious Diseases, School of Medicine, University of Duzce, Duzce, Turkey. dribak77@hotmail.com
authors.forename: Ibak
authors.initials: I
authors.lastname: Gonen
authors.forename: Hakan
authors.initials: H
authors.lastname: Turan
authors.forename: Davud
authors.initials: D
authors.lastname: Ozdemir
authors.forename: Ahmet
authors.initials: A
authors.lastname: Sahin
authors.forename: Ayhan
authors.initials: A
authors.lastname: Sarıtas
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001973:Bromodeoxyuridine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003693:Delirium / Q000209:etiology*; D016903:Drug Monitoring; D006562:Herpes Zoster / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D020258:Neurotoxicity Syndromes / Q000503:physiopathology*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; C020235:brivudine; D001973:Bromodeoxyuridine